DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Enteral Nutrition Market 2020-2030 by Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.
The Asia Pacific enteral nutrition market will grow by 9.7% annually with a total addressable market cap of $46.71 billion over 2020-2030 owing to rising number of patients suffering with chronic diseases and surge in adoption of enteral nutrition amid COVID-19 pandemic.
Highlighted with 34 tables and 55 figures, this report is based on a comprehensive research of the entire Asia Pacific enteral nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter's Five Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific enteral nutrition market in every aspect of the classification from perspectives of Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Country.
- Abbott Laboratories
- B. Braun Melsungen AG
- Baxter International, Inc.
- Danone S.A.
- Fresenius Kabi AG
- Asia Pacific Health Products, Inc.
- Hormel Foods Corporation
- Mead Johnson Nutrition Company
- Meiji Holdings Co., Ltd.
- Nestle S.A.
- Reckitt Benckiser Group LLC
- Victus, Inc.
Key Topics Covered:
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter's Five Forces Analysis
3 Segmentation of Asia Pacific Market by Nutrient
3.1 Market Overview by Nutrient
3.2 Protein Based Nutrition
3.2.1 Standard Protein Diet
3.2.2 High Protein Supplement
3.2.3 Protein for Diabetic Patients
3.2.4 Other Protein-based Nutitions
3.3 Carbohydrates Based Nutrition
3.4 Fat Based Nutrition
3.5 Vitamin Based Nutrition
3.6 Other Nutrition Types
4 Segmentation of Asia Pacific Market by Application
4.1 Market Overview by Application
4.2 Critical Care
4.6 Other Applications
5 Segmentation of Asia Pacific Market by Category
5.1 Market Overview by Category
5.2 Enteral Nutrition for Chronic Illness
5.3 Enteral Nutrition with Standard Formula
6 Segmentation of Asia Pacific Market by Product Form
6.1 Market Overview by Product Form
6.2 Liquid Enteral Nutrition
6.3 Powder Enteral Nutrition
7 Segmentation of Asia Pacific Market by End User
7.1 Market Overview by End User
8 Segmentation of Asia Pacific Market by Distribution Channel
8.1 Market Overview by Distribution Channel
8.2 Distribution by Hospitals
8.3 Distribution by Retail Pharmacies
8.4 Distribution by Online Pharmacies
9 Asia-Pacific Market 2019-2030 by Country
9.1 Overview of Asia-Pacific Market
9.6 South Korea
9.7 Rest of APAC Region
10 Competitive Landscape
10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
11 Investing in Asia Pacific Market: Risk Assessment and Management
11.1 Risk Evaluation of Asia Pacific Market
11.2 Critical Success Factors (CSFs)
For more information about this report visit https://www.researchandmarkets.com/r/pspvfm